Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04009005 · ClinicalTrials.gov registry record · NA
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
A NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome, sponsored by Terry L. Wahls.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04009005: Active NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome, sponsored by Terry L. Wahls.
NCT04009005 is a NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome that is active but no longer recruiting, run by Terry L. Wahls. The registered enrollment target is 44 participants, below the 201-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04009005, a NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome, is active but no longer recruiting, sponsored by Terry L. Wahls.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
A key question in efforts to reduce symptoms and improve quality of life for multiple sclerosis (MS) patients is whether a therapeutic lifestyle (diet, stress reduction and exercise) is inferior to disease-modifying drug treatments in terms of reducing multiple sclerosis related symptoms, improving function and quality of life. This study will prospectively assess the changes in quality of life and clinical outcomes in two cohorts of patients who are recently diagnosed with clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS) to begin answering that question. The goal of this project is to compare a diet and therapeutic lifestyle only treatment usual care in the setting of newly diagnosed individuals with RRMS or CIS, which is the precursor to the development of MS. Due to the COVID 19 Pandemic, the study was redesigned from an in-person study to a virtual visit only study prior to enrolling study subjects.
Primary Outcome
Composite scores for physical health subscales
Conditions Studied
Interventions
- BEHAVIORAL Therapeutic diet and lifestyle
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What the registry record for NCT04009005 still lists
NCT04009005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 201-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic diet and lifestyle is the first listed.
NCT04009005 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT04009005 about?
NCT04009005 is a clinical study titled "Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis". A key question in efforts to reduce symptoms and improve quality of life for multiple sclerosis (MS) patients is whether a therapeutic lifestyle (diet, stress reduction and exercise) is inferior to disease-modifying drug treatments in terms of reducing multiple sclerosis related symptoms, improving ...
What is the current status of trial NCT04009005?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2020-05-01. Estimated completion is 2027-09-01.
What conditions does trial NCT04009005 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis, Clinically Isolated Syndrome.
What interventions are being tested in trial NCT04009005?
The interventions under investigation include: Therapeutic diet and lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT04009005?
This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04009005 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04009005's enrollment target sits among peer trials
44 18th of 25 higher than 8 of 25 other Relapsing Remitting Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Relapsing Remitting Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
COMPLETED · NA
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
COMPLETED · NA
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI